From Trial Populations To Pricing: How Some Of The COVID-19 Vaccines Compare

With Phase III underway, Pfizer and Moderna’s clinical approaches and government contracting strategies are coming into focus.

COVID-19 vaccine

Now that Pfizer Inc. and Moderna, Inc. have launched Phase III programs for their COVID-19 vaccine candidates, industry and policy makers can start to envision what a world with an inoculation might look like, even as plenty of questions remain.

A US House hearing held a week before the trail announcements offered hints as to what the lawmakers will be...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet